ZyVersa Therapeutics, Inc. (ZVSA)

Why Is Inflammatory Disease-Focused ZyVersa Therapeutics Stock Trading Higher Today?

ZyVersa Therapeutics Inc (NASDAQ:ZVSA) announces the publication of an article in the peer-reviewed journal Acta Neuropathologica Communications, demonstrating that inflammasome activation enhances cancer metastasis to the brain in women with triple-negative breast cancer (TNBC). Up to 40% of women with TNBC experience metastasis to their brain. Published data demonstrate that inflammasome activation increases the proliferation of TNBC cells in the brain, which was prevented by inhibition of NLR